• Valproic acid produced marked reduction in myoclonus in a patient with dyssynergia cerebellaris myoclonica (DCM), resulting in substantial functional improvement. These results justify a trial of valproic acid in patients with DCM who are disabled by myoclonus.
Ernest R. Somerville, C. Warren Olanow. Valproic AcidTreatment of Myoclonus in Dyssynergia Cerebellaris Myoclonica. Arch Neurol. 1982;39(8):527–528. doi:10.1001/archneur.1982.00510200069016
* * Maintenance Notice * *
Maintenance will be performed from 11:00pm CT December 16, 2017 to 4:00pm CT December 17. Please be advised that your site/services may be periodically unavailable during this maintenance window.